Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BT Brands Q4 Sales $1.85M Down From $2.09M YoY

BT Brands (NASDAQ:BTBD) reported $1.85 million in sales this quarter. This is a 11.46 percent decrease over sales of $2.09 million the same period last year.

byBenzinga Newsdesk

March 16, 2022

1 minute read

BT Brands (NASDAQ:BTBD) reported $1.85 million in sales this quarter. This is a 11.46 percent decrease over sales of $2.09 million the same period last year.

JP Morgan Upgrades G1 Therapeutics to Neutral, Raises Price Target to $10

By Benzinga Newsdesk

Today, 4:52 AM

JP Morgan analyst Anupam Rama upgrades G1 Therapeutics (NASDAQ:GTHX) from Underweight to Neutral and raises the price target from $7 to $10.

GTHX

Savara Q2 EPS $(0.07) Up From $(0.16) YoY

By Michael Horton

Today, 4:52 AM

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.07) per share. This is a 56.25 percent increase over losses of $(0.16) per share from the same period last year.

SVRA

Rosenblatt Maintains Buy on Meta Platforms, Lowers Price Target to $300

By Benzinga Newsdesk

Today, 4:52 AM

Rosenblatt analyst Mark Zgutowicz maintains Meta Platforms (NASDAQ:FB) with a Buy and lowers the price target from $400 to $300.

Vericel Q1 2022 Earnings Conference Call On May 4, 2022 At 08:30 AM ET

By Benzinga Insights

Today, 4:52 AM

Vericel (NASDAQ:VCEL) will host a conference call at 08:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend Vericel (VCEL) Conference Call Follow this link to access the live webcast.

VCEL

BT Brands Q4 Sales $1.85M Down From $2.09M YoY

Related Posts

JP Morgan Upgrades G1 Therapeutics to Neutral, Raises Price Target to $10

Savara Q2 EPS $(0.07) Up From $(0.16) YoY

Rosenblatt Maintains Buy on Meta Platforms, Lowers Price Target to $300

Vericel Q1 2022 Earnings Conference Call On May 4, 2022 At 08:30 AM ET